endocrinologists dermatologists collaboration glp-1 care To our GLP-1 in Dermatology event sponsors, Your partnership makes it possible to bring together leading experts across dermatology, rheumatology, endocrinology, and gastroenterology for this Your Patient Is on a

Its cysteinyl thiol is the key reactive center, supporting reduction reactions, electrophile conjugation, and thiol-disulfide exchange

Consistent copy number changes and recurrent PRKAR1A mutations distinguish Melanotic Schwannomas from Melanomas: SNP-array and next generation sequencing analysis

Peer review Peer review information Nature Communications thanks the anonymous reviewers for their contribution to the peer review of this work

The most widely prescribed GLP-1 RAs for weight management include: Semaglutide sold as Ozempic (diabetes) and Wegovy (weight loss), administered by weekly subcutaneous injection Tirzepatide sold as Mounjaro (diabetes) and Zepbound (weight loss), a dual GIP/GLP-1 agonist administered by weekly injection Liraglutide sold as Saxenda (weight loss) and Victoza (diabetes), administered by daily injection GLP-1 RAs were originally developed as diabetes treatments but have become widely used for obesity and weight management following large clinical trials showing substantial weight loss outcomes